Misoprostol to the early abortion in adolescence

Authors

  • Belkis Rodríguez Vázquez Especialista de I Grado en Ginecología y Obstetricia. Asistente. Hospital Universitario "Abel Santamaría Cuadrado". Pinar del Río.
  • Abel García Bencomo Licenciado en Enfermería. Hospital Universitario "Abel Santamaría Cuadrado". Pinar del Río.
  • Ramón Valdés Carrillo Especialista de I Grado en Endocrinología. Hospital Universitario "Abel Santamaría Cuadrado". Pinar del Río.
  • Rosendo Sánchez Especialista de I Grado en Ginecología y Obstetricia. Hospital Universitario "Abel Santamaría Cuadrado". Pinar del Río.
  • Armando Martínez Fábregas Especialista de I Grado en Medicina Interna. Asistente. Hospital Universitario "Abel Santamaría Cuadrado". Pinar del Río.

Abstract

Abortion in adolescence continues to be a worldwide problem. That is why effective methods should be found to diminish morbidity and mortality due to its cause. Misoprostol would help to solve this health problem. Misoprostol (800 mcg) was used per vaginam and patients were followed sonographically repeating dosages when necessary up to three times. This method was used in 212 adolescents who attended to Abel Santamaría Hospital for abortion. These patients met all requirements and the method was used showing its safety and effectiveness. The average age was 17.1 years having a deviation of 1.2 years, the mean pregnancy time was 7 weeks, most of the patients were single (75.7 %). Side effects were: pain (90 %), diarrhea (33.7 %), headache (17.4 %) among others. The best expulsion stage was 6 to 8 hours (91.7 %). Patients having an endometrium > 24 mm (3.3 %) suffered from bleeding for more than 14 days without complications (there was no need of blood transfusion or curettage). The best effectiveness was obtained in patients between 7 and 10 weeks of pregnancy and the total effectiveness of the method was 99.05 % despite the first dosage was 97.64 %.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Rodríguez Vázquez B, García Bencomo A, Valdés Carrillo R, Sánchez R, Martínez Fábregas A. Misoprostol to the early abortion in adolescence. Rev Ciencias Médicas [Internet]. 2012 Oct. 5 [cited 2025 Aug. 30];8(2):62-8. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/200

Issue

Vol. 8 No. 2 (2004)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/